BD-pTau217 is an advanced blood-based biomarker that specifically targets central nervous system tau isoforms to detect Alzheimer’s disease pathology with precision. By filtering out background signal from non-neuronal sources, BD-pTau217 offers superior accuracy, giving researchers a clearer signal for earlier, more reliable detection.